No Data
No Data
No Data
No Data
No Data
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2024 Earnings Call Transcript
Yahoo Finance02:22
IDEXX Labs Price Target Cut to $570.00/Share From $655.00 by Barclays
IDEXX Labs Price Target Cut to $570.00/Share From $655.00 by Barclays
Dow Jones02:00
IDEXX Labs Is Maintained at Overweight by Barclays
IDEXX Labs Is Maintained at Overweight by Barclays
Dow Jones02:00
Barclays: The IDEXX Laboratories (IDXX.US) rating was maintained, and the target price was adjusted from $655.00 to $570.00.
Barclays: The IDEXX Laboratories (IDXX.US) rating was maintained, and the target price was adjusted from $655.00 to $570.00.
Zhitong Finance01:50
Barclays Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $570
Barclays analyst Balaji Prasad maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and lowers the price target from $655 to $570.
Benzinga01:50
IDEXX Laboratories Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 20.41% Barclays $655 → $570 Maintains Overweight 02/06/2024 33.09% JP Morgan $600 → $630 Mainta
Benzinga01:49
No Data
No Data